noch leicht abgeaendert zu gestern nacht - aber hier ist sie, Kinders:
881824 MEDI 500@ 48.20 - gelaufen -
901198 AFFX 300 @ 35.90
889323 HGSI 300 @ 32.40
901626 QGENF 500 @ 21.90
Nachdem, was gestern mit AFFYMETRIX passiert ist sind das genau die Werte, die mittelfristig $$$ machen werden. Und jetzt soll bloss keiner sagen, dass ich pushen wuerde - diese Unternehmen sind so gross, die kann man an einem Kleinzockerboard in good old Germany gar nicht pushen...hahaha!
Und hier meine Motivation:
LOS ANGELES, Jan 28 (Reuters) - Shares of genetic analysis firm Affymetrix Inc. slumped on Monday following a published report recommending that investors bet that the company's stock will decline, according to analysts.
Shares of the Santa Clara, California-based company were down 13.5 percent, or $4.94, to $31.84 late on Nasdaq, after slumping about 20 percent earlier to a session low of $29.50.
Several brokerage and analyst firms cited a report from buy-side consulting group Off Wall Street, based in Cambridge, Massachusetts, for the stock's tumble. Analysts said the report suggested investors short sell Affymetrix's stock, a technique used to profit from an anticipated decline in a company's stock price.
881824 MEDI 500@ 48.20 - gelaufen -
901198 AFFX 300 @ 35.90
889323 HGSI 300 @ 32.40
901626 QGENF 500 @ 21.90
Nachdem, was gestern mit AFFYMETRIX passiert ist sind das genau die Werte, die mittelfristig $$$ machen werden. Und jetzt soll bloss keiner sagen, dass ich pushen wuerde - diese Unternehmen sind so gross, die kann man an einem Kleinzockerboard in good old Germany gar nicht pushen...hahaha!
Und hier meine Motivation:
LOS ANGELES, Jan 28 (Reuters) - Shares of genetic analysis firm Affymetrix Inc. slumped on Monday following a published report recommending that investors bet that the company's stock will decline, according to analysts.
Shares of the Santa Clara, California-based company were down 13.5 percent, or $4.94, to $31.84 late on Nasdaq, after slumping about 20 percent earlier to a session low of $29.50.
Several brokerage and analyst firms cited a report from buy-side consulting group Off Wall Street, based in Cambridge, Massachusetts, for the stock's tumble. Analysts said the report suggested investors short sell Affymetrix's stock, a technique used to profit from an anticipated decline in a company's stock price.
Text zur Anzeige gekürzt. Gesamten Beitrag anzeigen »